CARsgen Therapeutics Holdings Limited
HKEX:2171.HK
3.08 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.013 | 0.013 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 49.824 | 0 | 51.998 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | -49.824 | 0 | -51.998 | 0 | 0 | 0 | 0.013 | 0.013 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0.169 | 0.169 | 0.162 | 0.162 | 0.182 | 0.182 | 0.158 | 0.158 | 0.163 | 0.163 | 0.088 | 0.088 | 0.078 | 0.078 | 0.063 | 0.063 |
| General & Administrative Expenses
| 0.033 | 0.033 | 0.031 | 0.031 | 0.036 | 0.036 | 0.031 | 0.031 | 0.031 | 0.031 | 0.032 | 0.032 | 0.028 | 0.028 | 0.01 | 0.01 |
| Selling & Marketing Expenses
| 0.002 | 0.002 | 56.114 | 0 | 81.667 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.035 | 0.035 | 0.031 | 0.031 | 0.037 | 0.037 | 0.032 | 0.032 | 0.031 | 0.031 | 0.032 | 0.032 | 0.028 | 0.028 | 0.01 | 0.01 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 0.188 | 0.188 | 0.22 | 0.22 | 0.265 | 0.265 | 0.187 | 0.187 | 0.185 | 0.185 | 2.196 | 2.196 | 0.259 | 0.259 | 0.267 | 0.267 |
| Operating Income
| -0.205 | -0.205 | -0.187 | -0.187 | -0.215 | -0.215 | -0.188 | -0.188 | -0.175 | -0.175 | -0.119 | -0.119 | -0.102 | -0.102 | -0.073 | -0.073 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.549 | -13.549 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.034 | 0.034 | -0.015 | -0.015 | -0.042 | -0.042 | -0 | -0 | 0.003 | 0.003 | -2.078 | -2.078 | -0.16 | -0.16 | -0.198 | -0.198 |
| Income Before Tax
| -0.171 | -0.171 | -0.202 | -0.202 | -0.257 | -0.257 | -0.188 | -0.188 | -0.171 | -0.171 | -2.197 | -2.197 | -0.262 | -0.262 | -0.27 | -0.27 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.286 | -13.286 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0.001 | 0.001 | 0 | 0 | 0.004 | 0.004 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -0.172 | -0.172 | -0.202 | -0.202 | -0.258 | -0.258 | -0.188 | -0.188 | -0.175 | -0.175 | -2.197 | -2.197 | -0.262 | -0.262 | -0.27 | -0.27 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.582 | -13.582 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.31 | -0.31 | -0.36 | -0.36 | -0.47 | -0.47 | -0.34 | -0.34 | -0.32 | -0.32 | -9.84 | -9.84 | -1.32 | -1.32 | -1.36 | -1.36 |
| EPS Diluted
| -0.31 | -0.31 | -0.36 | -0.36 | -0.47 | -0.47 | -0.34 | -0.34 | -0.32 | -0.32 | -9.84 | -9.84 | -1.32 | -1.32 | -1.36 | -1.36 |
| EBITDA
| -0.188 | -0.188 | -0.171 | -0.171 | -0.197 | -0.197 | -0.177 | -0.177 | -0.165 | -0.165 | -0.111 | -0.111 | -0.093 | -0.093 | -0.065 | -0.065 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.807 | -12.807 | 0 | 0 | 0 | 0 | 0 | 0 |